glp-1 agonists blindness risk Do GLP-1s cause in people with Diabetes? A brand-new JAMA study looked at over 275 million patient records to find out. -Slightly higher of new-onset diabetic retinopathy in patients with The cardiovascular effects of GLP-1

(January 1988)

Losing muscle reduces resting metabolic rate and makes weight regain more likely

41,42,43 It endows mitochondria with different shapes accompanied by changes in quantity and quality of mitochondria, thus finally affecting cell metabolism and function

Genetic and physiological insights into satiation variability predict responses to obesity treatment

By preserving crucial NAD+ levels, it encourages your body to burn stored fat for fuel

Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study